About
Neurolentech develops patient-derived neuronal cell models to accelerate drug discovery for neurodevelopmental disorders such as epilepsy, severe autism, and intellectual disability.
Explore Neurolentech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.